EXTON,
Pa., Jan. 28, 2025 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
today that the Company's Board of Directors has approved a
first-quarter 2025 dividend of $0.21 per share. The
dividend will be paid on February 11, 2025, to shareholders of
record as of February 7, 2025.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or
its subsidiaries, in the United States and other
jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-announces-first-quarter-dividend-302362284.html
SOURCE West Pharmaceutical Services, Inc.
